Protalix BioTherapeutics, Inc. Business Finance Contracts & Agreements

30 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Capital Stock
Stock Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2024
Description of Capital Stock
Stock Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2023
Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Form of Exchange Agreement, dated as of August 12, 2021 among Protalix BioTherapeutics, Inc. and the Existing Holders
Exchange Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Binding Term Sheet between Protalix Ltd. and Chiesi Farmaceutici S.p.A
Term Sheets
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated February 11, 2021, between the Company and BofA Securities, Inc
Underwriting Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2021
Form of Stock Option Agreement (Standard)
Stock Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2020
Form of Stock Option Agreement (Executives)
Stock Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2020
Form of Securities Purchase Agreement
Purchase Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2020
Form of Warrant
Warrant Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2020
Description of Capital Stock
Stock Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2020
Second Supplemental Indenture, dated as of November 27, 2017, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of July 24, 2017
Exchange Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
NOTE PURCHASE AGREEMENT
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
FORM OF FACE OF NOTE
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2017
FIRST SupplementalIndenture between PROTALIXBIOTHERAPEUTICS, INC., as Issuer, ANDEACH OF THE GUARANTORS PARTY HERETO, and TheBank of New York Mellon Trust CoMPANY, N.A., as...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
Protalix BioTherapeutics, Inc. (Company) The Bank of New York Mellon Trust Company, N.A.,as Trustee (Trustee) 4.50% Convertible Senior Notes due 2022 INDENTURE Dated as of July...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2017
Dated 7 December 2016 BETWEEN PROTALIX BIOTHERAPEUTICS, INC. as the Company AND ALTSHULER SHAHAM TRUSTS LTD. as Security Trustee FORM OF SECURITY AGREEMENT/DEBENTURE UNLIMITED IN...
Debenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
FORM OF SECURITY AGREEMENT dated as of December 7, 2016 among PROTALIX BIOTHERAPEUTICS, INC. THE GUARANTORS PARTY HERETO and WILMINGTON SAVINGS FUND SOCIETY, FSB, as Collateral...
Security Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
FORM OF EXCHANGE AGREEMENT by and among Protalix BioTherapeutics, Inc. and the Parties Signatory Hereto Dated as of December 1, 2016
Exchange Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
FORM OF NOTE PURCHASE AGREEMENT
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
Principal Amount $40,186,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible...
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
Principal Amount $22,500,000 as revised by the Schedule of Increases and Decreases of Global Note attached hereto Protalix BioTherapeutics, Inc. 7.50% Senior Secured Convertible...
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
PROTALIX BIOTHERAPEUTICS, INC. AS ISSUER AND EACH OF THE GUARANTORS PARTY HERETO 7.50% SENIOR SECURED CONVERTIBLE NOTESDUE 2021 INDENTURE DATED AS OF DECEMBER 7, 2016 THE BANK OF...
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2016
ProtalixBioTherapeutics, Inc. $60,000,0004.50% Convertible Notes Due 2018 PurchaseAgreement
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2013
[FACE OF NOTE]
Note Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2013
ProtalixBioTherapeutics, Inc. (Company) The Bankof New York Mellon Trust Company, N.A. (Trustee) 4.50%Convertible Senior Notes due 2018 INDENTURE Datedas of September 18, 2013
Indenture Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2013
Protalix BioTherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2012
Underwriting Agreement
Underwriting Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
NY
2007
EX-4.1 Form of Warrant
Warrant Agreements
Protalix BioTherapeutics, Inc.
Biotechnology
2007